Medley (4480) AI Stock Analysis

• Market Cap: €83.61B
• Dividend Yield: N/A
• Average Volume (3M): 689.62K
• Price to Earnings (P/E): 57.5
• Beta (1Y): 0.52
• Revenue Growth: 34.77%
• EPS Growth: -46.50%
• Country: JP
• Employees: 1,487
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 22.39
• Shares Outstanding: 32,738,600
• 10 Day Avg. Volume: 440,110
• 30 Day Avg. Volume: 689,620
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €4,203.58
• Price Target Upside: 65.56% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 60 Neutral
• Price Target: ¥2,839.00 ▲(11.82% Upside)

Medley, Inc. demonstrates strong financial performance, which is the most significant factor supporting the stock. However, technical indicators suggest bearish momentum, and the high P/E ratio raises valuation concerns. These factors collectively result in a moderate overall stock score.

Medley Business Overview & Revenue Model

Company Description

Medley (4480) is a Japanese company operating in the healthcare and medical sector, primarily engaged in providing online healthcare services. Medley offers a range of digital solutions, including online medical consultation platforms, medical information services, and recruitment support for medical professionals. The company's core offerings are designed to enhance accessibility to medical services and improve the efficiency of healthcare operations.

How the Company Makes Money

Medley generates revenue through a variety of streams. Its primary revenue model includes subscription fees from healthcare professionals and institutions that use its online platforms for medical consultations and information services. Additionally, Medley earns income from recruitment services by charging fees to medical facilities and professionals for matching services. The company also partners with healthcare organizations and governments to provide tailored digital healthcare solutions, contributing to its revenue. Significant partnerships with medical institutions and a growing demand for digital healthcare services are key factors driving Medley's earnings.

Medley Financial Statement Overview

Summary

Medley, Inc. is in a strong financial position with impressive revenue and profit growth, stable cash flow generation, and a well-capitalized balance sheet. While there are areas to monitor, such as operational efficiency and investment returns, the overall financial health supports continued growth.

Income Statement

Medley, Inc. has demonstrated strong revenue growth, with a significant increase from 2023 to 2024, indicating a positive growth trajectory. The gross profit margin remains robust, and the net profit margin is healthy, reflecting efficient cost management. However, the slight decline in EBIT margin suggests potential pressure on operational efficiency.

Balance Sheet

The company's balance sheet is stable, with a solid equity base and a healthy debt-to-equity ratio, indicating low financial leverage. The equity ratio is also strong, reflecting a well-capitalized structure. However, the increase in total liabilities warrants monitoring, as it could impact future financial flexibility.

Cash Flow

Medley, Inc. exhibits strong cash flow generation, with positive free cash flow and a favorable operating cash flow to net income ratio. The free cash flow growth rate is commendable, suggesting efficient capital expenditure management. Despite this, the significant negative investing cash flow highlights substantial investments, which could pose risks if not yielding expected returns.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	31.50B	29.30B	20.53B	14.19B	10.86B	6.83B
Gross Profit	20.22B	18.92B	13.59B	9.72B	6.99B	4.67B
EBITDA	5.67B	4.00B	4.50B	2.14B	1.25B	586.57M
Net Income	2.26B	2.80B	2.57B	1.02B	563.00M	455.99M
Balance Sheet
Total Assets	48.97B	45.20B	25.43B	21.81B	20.21B	15.52B
Cash, Cash Equivalents and Short-Term Investments	14.15B	19.00B	15.35B	14.42B	14.29B	14.05B
Total Debt	19.85B	15.18B	1.66B	2.38B	3.11B	4.18B
Total Liabilities	30.47B	24.98B	7.79B	6.64B	6.16B	5.80B
Stockholders Equity	18.50B	20.21B	17.55B	15.08B	13.97B	9.72B
Cash Flow
Free Cash Flow	0.00	2.38B	3.47B	1.64B	796.39M	591.87M
Operating Cash Flow	0.00	2.45B	3.87B	2.01B	1.04B	805.76M
Investing Cash Flow	0.00	-10.72B	-1.66B	-751.00M	-3.29B	-283.15M
Financing Cash Flow	0.00	11.90B	-1.22B	-927.00M	2.22B	9.05B

Medley Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 2539.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4480, the sentiment is Neutral. The current price of 2539 is above the 20-day moving average (MA) of 2494.25, below the 50-day MA of 2873.22, and below the 200-day MA of 3278.00, indicating a neutral trend. The MACD of -123.13 indicates Negative momentum. The RSI at 45.35 is Neutral, neither overbought nor oversold. The STOCH value of 76.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4480.

Medley Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2175	73 Outperform	141.94B	19.97	12.79%	1.75%	10.66%	0.41%
3939	72 Outperform	23.24B	22.85	23.99%	1.32%	13.39%	12.00%
4483	66 Neutral	310.61B	50.07	9.63%	0.34%	29.09%	87.01%
4480	60 Neutral	€83.61B	57.53	8.00%	―	34.77%	-46.50%
4263	45 Neutral	14.97B	-50.86	0.00%	―	35.15%	16.85%
3902	43 Neutral	23.05B	-32.08	0.00%	1.08%	-0.58%	-260.22%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Medley Corporate Events

Medley, Inc. Expands Share Repurchase Program

Medley, Inc. has announced an expansion of its share repurchase framework and an extension of the repurchase period to enhance shareholder returns and adapt to market trends. The company plans to increase the number of shares repurchased to 1,050,000 and the aggregate repurchase amount to 3,000 million yen, with the period extended until December 31, 2025.

The most recent analyst rating on (JP:4480) stock is a Buy with a Yen7400.00 price target. To see the full list of analyst forecasts on Medley stock, see the JP:4480 Stock Forecast page.

Medley Records Extraordinary Loss Post-Merger

Medley, Inc. announced an extraordinary loss of 783 million yen due to an absorption-type merger with its wholly-owned subsidiaries, Offshore Inc. and GUPPY’s Inc. This loss, recorded in the non-consolidated financial statements for the first half of 2025, will not affect the company’s consolidated profit and loss, ensuring stability in its overall financial health.

The most recent analyst rating on (JP:4480) stock is a Buy with a Yen7400.00 price target. To see the full list of analyst forecasts on Medley stock, see the JP:4480 Stock Forecast page.

Medley, Inc. Announces Change in Major Shareholder

Medley, Inc. announced a change in its major shareholder, with OLP Capital Management Limited reducing its shareholding from 10.83% to 9.57%. This change in shareholding is based on a large-volume shareholding report, and the company states that it does not foresee any significant impact on its operations or outlook.

The most recent analyst rating on (JP:4480) stock is a Buy with a Yen7400.00 price target. To see the full list of analyst forecasts on Medley stock, see the JP:4480 Stock Forecast page.